Grace Therapeutics Inc (GRCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 09-2013 | 08-2013 | 06-2013 | 05-2013 | 03-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,010 | -5,010 | -1,920 | -1,920 | -6,900 |
| Depreciation Amortization | 640 | 640 | 160 | 160 | 660 |
| Other Working Capital | 1,750 | 1,750 | 320 | 320 | 1,830 |
| Other Operating Activity | 1,450 | 1,450 | 520 | 520 | 1,860 |
| Operating Cash Flow | $-1,170 | $-1,170 | $-920 | $-920 | $-2,550 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | 770 | 770 | 560 | 560 | 1,900 |
| Investing Cash Flow | $770 | $770 | $560 | $560 | $1,900 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 380 | 380 | 10 | 10 | 220 |
| Financing Cash Flow | $380 | $380 | $10 | $10 | $220 |
| Exchange Rate Effect | 10 | 10 | 4 | 4 | 30 |
| Beginning Cash Position | 1,150 | 1,150 | 1,170 | 1,170 | 1,590 |
| End Cash Position | 1,160 | 1,160 | 830 | 830 | 1,190 |
| Net Cash Flow | $9 | $9 | $-330 | $-330 | $-390 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,170 | -1,170 | -920 | -920 | -2,550 |
| Free Cash Flow | -1,170 | -1,170 | -920 | -920 | -2,550 |